Form 4 Tracker
Natera, Inc.
NTRA

118 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 1, 2026Jul 7 1:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
3,000$272.90$818.7K134,643(D)

View →

Jul 6, 2026Jul 6 8:56 PMTINKERBELLE II TR U/A DTD 10/22/2021
Proposed Sale
1,000$280.00$280.0K

View →

Jul 1, 2026Jul 1 8:15 PMDANIEL RABINOWITZ
Proposed Sale
16,800$271.45$4.6M

View →

Jul 1, 2026Jul 1 8:13 PMSOLOMON MOSHKEVICH
Proposed Sale
3,000$272.90$818.7K

View →

Jun 24, 2026Jun 27 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
33,600$251.65$8.5M189,094(D)

View →

Jun 24, 2026Jun 27 1:05 AMHerm RosenmanDirector
Sale
16,530$250.00$4.1M4,250(D)

View →

Jun 24, 2026Jun 24 8:36 PMDANIEL RABINOWITZ
Proposed Sale
33,600$234.76$7.9M

View →

Jun 24, 2026Jun 24 8:21 PMHERMAN ROSENMAN
Proposed Sale
16,530$250.00$4.1M

View →

Jun 17, 2026Jun 23 1:05 AMJonathan SheenaDirector, Other
Sale
1,500$219.87$329.8K18,782(I)

View →

Jun 16, 2026Jun 18 1:05 AMRowan E ChapmanDirector
Sale
2,964$216.78$642.5K3,124(D)

View →

Jun 15, 2026Jun 18 1:05 AMJonathan SheenaDirector, Other
Sale
3,150$211.14$665.1K249,352(D)

View →

Jun 15, 2026Jun 17 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
50,000$214.91$10.7M2,277,843(D)

View →

Jun 12, 2026Jun 17 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
50,000$214.03$10.7M2,327,843(D)

View →

Jun 16, 2026Jun 16 8:02 PMROWAN EMMA CHAPMAN
Proposed Sale
2,964$216.78$642.5K

View →

Jun 12, 2026Jun 12 8:42 PMMATTHEW RABINOWITZ
Proposed Sale
100,000$219.23$21.9M

View →

Jun 5, 2026Jun 10 1:05 AMGail Boxer MarcusDirector
Sale
11,000$217.21$2.4M6,183(D)

View →

Jun 4, 2026Jun 6 1:05 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
41,124$221.03$9.1M108,743(D)

View →

Jun 5, 2026Jun 5 9:15 PMGAIL MARCUS
Proposed Sale
11,000$217.21$2.4M

View →

Jun 4, 2026Jun 4 9:03 PMSTEVEN L CHAPMAN
Proposed Sale
41,124$221.03$9.1M

View →

Jun 1, 2026Jun 4 1:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
3,000$218.43$655.3K137,643(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 10 1:05 AMGail Boxer MarcusDirector
Option Exercise
11,000$22.8311,000(D)

View →

Apr 6, 2026Apr 9 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
58,292$9.590(D)

View →

Mar 31, 2026Apr 2 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
41,708$9.5958,292(D)

View →

Mar 16, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
50,000$9.59100,000(D)

View →

Mar 13, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59150,000(D)

View →

Mar 12, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59225,000(D)

View →

Mar 6, 2026Mar 11 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
5,598$19.680(D)

View →

Mar 2, 2026Mar 4 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Option Exercise
5,125$9.590(D)

View →

Jan 20, 2026Jan 23 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Option Exercise
3,3860(D)

View →

Jan 20, 2026Jan 23 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Option Exercise
1,5220(D)

View →

Jan 20, 2026Jan 23 2:05 AMJonathan SheenaDirector, Other
Option Exercise
1910(D)

View →

Jan 20, 2026Jan 23 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
8560(D)

View →